CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Mallinckrodt Hospital Products Inc. recalls Acthar Gel (repository…

Mallinckrodt Hospital Products Inc. recalls Acthar Gel (repository corticotropin injection)

Read the official FDA notice

Published
2 Sept 2026
Units affected
12367 vials
Agency
FDA
Country
United States

The hazard

Presence of particulate matter: glass and stopper piece

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1 & NDC 63004-8710-2

Brand / company
Mallinckrodt Hospital Products Inc.
Codes / lots
Lot#: NDC 63004-8710-1 - 1564-107, exp 1/31/2027 NDC 63004-8710-2 - 1564-107H, exp 1/31/2027
Distribution
USA Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 2 Sept 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.